Customized quality controls for analytical assays

Patent metadata

Field	Value
Publication number	US-9354144-B2
Application number	US-201213594227-A
Country	US
Kind code	B2
Filing date	Aug 24, 2012
Priority date	Sep 20, 2011
Publication date	May 31, 2016
Grant date	May 31, 2016

Abstract

Solid beads each containing a selected quantity of analyte are combined and a liquid base matrix that contains attributes of a biological fluid that is to be assayed, together constitute a kit from which a laboratory technician can, at the point of use, prepare a liquid control for a particular analyte, and preferably a series of such controls at different levels of the same analyte customized for a particular assay.

First claim

What is claimed is:

1. A method for preparing a set of controls for an assay of one or more selected analytes in a sample of human biological fluid by a selected assay technique, said assay to determine a concentration of each of said analytes in said sample relative to a known medical decision point concentration for that analyte, said method comprising:
dissolving a plurality of quantities of one or more solid water-soluble beads in separate aliquots of an aqueous liquid matrix, the aliquots having equal volumes of the aqueous liquid matrix,
wherein each said water-soluble bead is prepared by lyophilization of an aqueous solution ranging in volume from about 5 μL to about 1,000 μL and comprises at least one said analyte, a bulking agent, a salt, and a buffer, and
said aqueous liquid matrix comprising a salt and a buffer at a pH of from about 4.0 to about 9.0,

to form a plurality of liquid solutions having a range of concentrations for each said analyte, the range bracketing said medical decision point concentration for that analyte,
such that the concentration of each of said analytes is less than or equal to said medical decision point concentration in at least one liquid solution, and the concentration of each of said analytes is greater than or equal to said medical decision point concentration in at least one liquid solution.

2. The method of claim 1 wherein said assay technique has a detection limit and said analytes when present in said matrix are below said detection limit.

3. The method of claim 1 wherein at least one of said solid water-soluble beads consists essentially of at least one said analyte, said bulking agent, said salt, and said buffer.

4. The method of claim 1 comprising preparing a set of controls for assays of a plurality of distinct selected analytes, said assays to determine the concentration of each of said analytes relative to a known medical decision point concentration for that analyte, wherein the set of controls is prepared by dissolving a plurality of quantities of each of a plurality of distinct water-soluble beads, each distinct water-soluble bead containing a single distinct analyte, in separate aliquots of said aqueous liquid matrix, to form a plurality of liquid solutions whose concentrations of each analyte define a range that brackets said medical decision point concentration for that analyte.

5. The method of claim 1 wherein said aqueous liquid matrix comprises human or animal source materials from which endogenous species that interfere with the detection of said analytes have been removed.

6. The method of claim 1 wherein said aqueous liquid matrix further comprises an albumin.

7. The method of claim 1 wherein said aqueous liquid matrix further comprises a stabilizer selected from the group consisting of a protease inhibitor, a cryoprotectant, a reducing agent, a chelating agent, a crosslinking agent, and a surfactant.

8. The method of claim 1 wherein said aqueous liquid matrix further comprises an antimicrobial agent selected from the group consisting of sodium azide, ciprofloxacin, chloramphenicol, gentamicin, amikacin, tobramycin, and amphotericin B.

9. The method of claim 1 wherein said aqueous liquid matrix has a pH of from about 6.2 to about 8.5.

10. The method of claim 1 wherein said aqueous liquid matrix has an osmolarity of from about 50 to about 1,000 mOsm/kg.

11. The method of claim 1 wherein each said water-soluble bead is substantially spherical with a diameter of from about 3 mm to about 10 mm.

12. The method of claim 5 wherein said human or animal source materials comprise a human biological fluid.

13. The method of claim 6 wherein said albumin is selected from the group consisting of human serum albumin and bovine serum albumin.

14. A method for preparing a set of controls for an assay of one or more selected analytes in a sample of human biological fluid by a selected assay technique, said assay to determine a concentration of each of said analytes in said sample relative to a known medical decision point concentration for that analyte, said method comprising:
dissolving a quantity of one or more solid water-soluble beads in separate aliquots of an aqueous liquid matrix, wherein the same quantity of beads is dissolved in each aliquot, and the aliquots have different volumes of the aqueous liquid matrix,
wherein each said water-soluble bead is prepared by lyophilization of an aqueous solution ranging in volume from about 5 μL to about 1,000 μL and comprises at least one said analyte, a bulking agent, a salt, and a buffer, and
said aqueous liquid matrix comprising a salt and a buffer at a pH of from about 4.0 to about 9.0,

to form a plurality of liquid solutions having a range of concentrations for each said analyte, the range bracketing said medical decision point concentration for that analyte,
such that the concentration of each of said analytes is less than or equal to said medical decision point concentration in at least one liquid solution, and the concentration of each of said analytes is greater than or equal to said medical decision point concentration in at least one liquid solution.

15. The method of claim 14 , wherein each liquid solution is formed by dissolving a single water-soluble bead in an aliquot of the aqueous liquid matrix.

16. The method of claim 14 , wherein each water-soluble bead comprises a single analyte.

17. The method of claim 14 , wherein each water-soluble bead comprises two or more analytes.

18. The method of claim 1 , wherein at least one liquid solution is formed by dissolving a single water-soluble bead in an aliquot of the aqueous liquid matrix.

19. The method of claim 1 , wherein each water-soluble bead comprises a single analyte.

20. The method of claim 1 , wherein each water-soluble bead comprises two or more analytes.

Assignees

• Ebrahim Alireza
• Spates Christopher
• Vore Karl De
• Bio Rad Laboratories

Inventors

• Ebrahim Alireza
• Spates Christopher
• Vore Karl De

Classifications

• G01N33/96 Primary

  involving blood or serum control standard · CPC title

• G01N2496/00

  Reference solutions for assays of biological material · CPC title

• G01N21/91

  using penetration of dyes, e.g. fluorescent ink · CPC title

• G01N1/28 Primary

  Preparing specimens for investigation {including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q}(mounting specimens on microscopic slides G02B21/34; means for supporting the objects or the materials to be analysed in electron microscopes H01J37/20 {; laboratory gas handling apparatus B01L5/00}) · CPC title

• G01N2333/765

  Serum albumin, e.g. HSA · CPC title